A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior

Key Clinical Message Distinguishing chronic lymphoproliferative disorder of NK-cells from aggressive NK-cell leukemia is critical because they have distinct clinical course and management. Immunophenotyping plays a key role in distinguishing these two entities, however, it could not be used as sole criteria and clinical/laboratory findings are equally important.